More than 300,000 patients with life-ruining incontinence to get breakthrough drug, free on the NHS READ MORE: High Street shops cynical price hikes on vital incontinence pads By Meike Leonard Published: 10:22 EDT, 8 August 2024 | Updated: 10:29 EDT, 8 August 2024 e-mail View comments More than 300,000 patients with life-ruining incontinence are set to receive a breakthrough drug that significantly boost the ability to 'hold on'. The daily pill, called vibegron, works by relaxing the bladder muscles, allowing it to store more urine. In new guidance published by the Health Service's regulatory body today, the medication was recommended for adults suffering with overactive bladder (OAB).
Around 330,000 people in England will be eligible to receive the treatment free on the NHS. OAB syndrome causes sudden urges to urinate that can be hard to control and can lead sufferers to soil themselves. Millions of Brits suffering from overactive bladder syndrome (OAB) could benefit from a new daily pill which has been greenlit by UK health officials (stock image) Officials from the Medicines and Healthcare products Regulatory Agency (MHRA) gave the drug vibegron, sold under the brand Obgemsa in the EU and Gemtesa in the US, approval for use in British patients with overactive bladder syndrome Symptoms may include a sudden need to empty the bladder, urinating more frequently, and urinary incontinence.
The condition is relatively common amongst older adults but can also be caused by abdomina.